Latest News & Features
Americas
Generic drug makers Sandoz, Mylan and Natco have asked the US Supreme Court to immediately put into effect its ruling on the validity of a patent covering Teva’s multi-billion dollar multiple sclerosis drug Copaxone. 27 January 2015
Americas
Genetic diagnostic companies Myriad Genetics and Pathway Genomics have settled their patent dispute involving BRCA gene testing. 27 January 2015
Americas
The US Supreme Court has sent back three patent cases to the US Court of Appeals for the Federal Circuit for further consideration following its ruling on Teva v Sandoz last Tuesday. 27 January 2015
Americas
Eli Lilly has sued health care company Fresenius for allegedly infringing a patent covering its $2 billion-a-year lung cancer drug Alimta. 26 January 2015
Americas
The US Court of Appeals for the First Circuit has upheld class certification in the Nexium pay-for-delay case. 26 January 2015
Europe
The English High Court has said it will not send a patent infringement case filed by Pfizer-owned Warner-Lambert Company against Actavis to trial, finding there was no “serious issue”. 22 January 2015
Americas
Police in Canada have seized thousands of counterfeit drugs as part of an operation that targeted gangs including the Hells Angels. 21 January 2015
Americas
Teva has filed for a declaratory judgment that it did not infringe patents belonging to AstraZeneca and Amylin Pharmaceuticals that protect diabetes drug Byetta (exenatide). 21 January 2015
Americas
The recent merger of law firms Edwards Wildman Palmer and Locke Lord has made way for the migration of an 18-strong team of life sciences lawyers to law firm Mintz Levin Cohn Ferris Glovsky and Popeo. 20 January 2015
Americas
US-based Supernus Pharmaceuticals has sued generic drug maker Par Pharmaceutical for allegedly infringing four patents covering its extended release anti-epileptic drug Trokendi XR (topiramate), the company announced on Friday. 20 January 2015